Chemical Compound
(2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetoxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2,4-dimethyltetrahydro-2H-pyran-3-yl 3-methylbutanoate
CAS Registry Number
16846-24-5
Primary record
(2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetoxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2,4-dimethyltetrahydro-2H-pyran-3-yl 3-methylbutanoate
- 库存
- 8,669 克
- 纯度
- 98.2 %
- CAS
- 16846-24-5
化合物标识与属性
- CAS
- 16846-24-5
- PubChem CID
- 5282165
- SMILES
- C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O
- Canonical SMILES
- CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O
名称与同义词
- josamycin
- Leucomycin A3
- Turimycin A5
- Kitasamycin A3
- Josamycine
- Josamicina
- Josamycinum
- iosalide
- josamina
- Josacine
- Jomybel
- Antibiotic yl-704 A3
- Wilprafen
- 16846-24-5
- Josamycin CRS
- Josamycine [INN-French]
- Josamycinum [INN-Latin]
- Josamicina [INN-Spanish]
- josamycin propionate
- josamycin proprionate
- Josamycin (Standard)
- Yl-704 A3
- JOSAMYCIN [INN]
- JOSAMYCIN [JAN]
- JOSAMYCIN [MI]
- EN-141
- AC1NQZL5
- JOSAMYCIN [USAN]
- RefChem:150573
- GlyTouCan:G83747IH
- HV13HFS217
- UNII-HV13HFS217
- Leucomycin V, 3-acetate 4B-(3-methylbutanoate)
- Josamycin [USAN:INN:JAN]
- JOSAMYCIN [MART.]
- JOSAMYCIN [WHO-DD]
- CCRIS 8511
- C42H69NO15
- Leucomycin A3 (>90%)
- DTXSID8023183
- CHEBI:31739
- SCHEMBL132829
- EINECS 240-871-6
- EN 141
- Josamycin [USAN:INN:BAN:JAN]
- MFCD00210320
- XJSFLOJWULLJQS-NGVXBBESSA-N
- CHEMBL224436
- DTXCID103183
- EN141
- orb1300028
- orb3025426
- Josamycin (JP18/USAN/INN)
- JOSAMYCIN [EP MONOGRAPH]
- Leucomycin V 3-acetate 4b-(3-methylbutanoate)
- GTPL12924
- HY-B1920R
- Josamycin for peak identification
- J01FA07
- MSK7809
- Josamycin, >=98.0% (UV)
- XJSFLOJWULLJQS-HTYUZQQASA-N
- G83747IH
- HY-B1920
- YL-704A3
- Josamycin 10 microg/mL in Acetonitrile
- 8158AH
- BBF-01904
- MSK7809-100M
- NSC122223
- s4421
- ZINC96006021
- Josamycin for peak identification CRS
- ST075007
- C42-H69-N-O15
- Leucomycin A3 (Kitasamycin component)
- MSK7809-1000M
- AL24876
- CID5282165
- DB01321
- CID:5282165
- LS-87883
- Josamycin 1000 microg/mL in Acetonitrile
- Josamycin Solution in Methanol, 100ug/mL
- Leucomycin V, 3-acetate 4(sup B)-(3-methylbutanoate)
- SID:134223523
- Josamycin Solution in Methanol, 1000ug/mL
- Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate)
- LS-185083
- TR-007321
- CS-0013975
- FT-0630434
- Josamycin; Josamycin Propionate EP Impurity E
- C12662
- D01235
- D81953
- Leucomycin V 3-acetate 4(beta)-(3-methylbutanoate)
- D015570
- leucomycin V 3-acetate 4(B)-(3-methylbutanoate)
- leucomycin V 3-acetate 4beta-(3-methylbutanoate)
- Q423369
- SR-01000883731
- A1201005
- EN-141;Kitasamycin A3;Leucomycin A3;Turimycin A5
- JM
- SR-01000883731-1
- [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate
- Josamycin, European Pharmacopoeia (EP) Reference Standard
- Stereoisomer of 4-(acetyloxy)-6-((3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-4-O-(3-methyl-1-oxobutyl)-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranosyl)oxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-diene-7-acetaldehyde
- Stereoisomer of 7-(formylmethyl)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-6-yl 3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranoside 4'-acetate 4''-isovalerate
- LEUCOMYCIN V, 3-ACETATE 4(SUP .BETA.)-(3-METHYLBUTANOATE)
- [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetoxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyl-tetrahydropyran-3-yl]oxy-4-hydroxy-2,4-dimethyl-tetrahydropyran-3-yl] 3-methylbutanoate
- Stereoisomer of 7-(formylmethyl)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-6-yl 3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranoside 4'-acetate 4'-isovalerate
- hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate
- Josamycin for peak identification, European Pharmacopoeia (EP) Reference Standard
- ((2S,3S,4R,6S)-6-((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl)oxy-4-hydroxy-2,4-dimethyloxan-3-yl) 3-methylbutanoate
- ((2S,3S,4R,6S)-6-((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-dimethylamino-5-hydroxy-2-methyloxan-3-yl)oxy-4-hydroxy-2,4-dimethyloxan-3-yl) 3-methylbutanoate
- (2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9, 16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11, 13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl)oxy)-4-hydroxy-2, 4-dimethyloxan-3-yl 3-methylbutanoate
- (2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl)oxy)-4-hydroxy-2,4-dimethyloxan-3-yl 3-methylbutanoate
- (2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetoxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2,4-dimethyltetrahydro-2H-pyran-3-yl 3-methylbutanoate
- (2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl 3-methylbutanoate
- (3R,4S,5S,6R,8R,9R,10E,12E,15R)-3-Acetoxy-5-(2,6-dideoxy-4-O-(3-methylbutanoyl)-3-C-methyl-alpha-L-ribo-hexopyranosyl-(1->4)-3,6-dideoxy-3-dimethylamino-beta-D-glucopyranosyloxy)-6-formylmethyl-9-hydroxy-4-methoxy-8-methylhexadeca-10,12-dien-15-olide
- [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-
- [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxa
- [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-dimethylamino-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate
- 240-871-6
- 56689-45-3
- 6-{6-[(1S,13S,2R,3R,7R,14R,16R)-3-acetyloxy-13-hydroxy-2-methoxy-7,14-dimethyl -5-oxo-16-(2-oxoethyl)-6-oxacyclohexadeca-9,11-dienyloxy](3S,2R,4R,5R,6R)-4-(d imethylamino)-5-hydroxy-2-methyl(2H-3,4,5,
- 6-{6-[3-Acetyloxy-13-hydroxy-2-methoxy-7,14-dimethyl-6-oxa-5-oxo-16-(2-oxoethyl)cyclohexadeca-9,11-dienyloxy]-4-(dimethylamino)-5-hydroxy-2-methylperhydro-2H-pyran-3-yloxy}-4-hydroxy-2,4-dimethylperhydro-2H-pyran-3-yl 3-methylbutanoate
- 6-tetrahydropyran-3-yloxy)}(2S,3S,4R ,6R)-4-hydroxy-2,4-dimethyl-2H-3,4,5,6-tetrahydropyran-3-yl 3-methylbutanoate
- Josamycin; (4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-6-[[3,6-dideoxy-4-O-[2,6-dideoxy-3-C-methyl-4-O-(3-methylbutanoyl)-a-l-ribo-hexopyranosyl]-3-(dimethylamino)-ss-d-glucopyranosyl]oxy]-10-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-2-one